PharmaLegacy Laboratories completes acquisition of BTS Research to strengthen preclinical services and expand operations
Acquiring Company
PharmaLegacy Laboratories
Acquired Company
BTS Research
San DiegoHealth CareBiotechnologyDescription
PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has strategically acquired BTS Research, a San Diego-based CRO. This acquisition strengthens and expands PharmaLegacy’s global research capabilities and service offerings, allowing them to better serve clients across North America and advance their position as an industry-leading preclinical CRO.
Quick answer
PharmaLegacy Laboratories is acquiring BTS Research, announced September 16, 2024.
- How much did PharmaLegacy Laboratories pay for BTS Research?
- The deal value was not disclosed.
- What does PharmaLegacy Laboratories do?
- PharmaLegacy Laboratories is a reputable provider of in vitro and in vivo preclinical drug development services, offering a wide range of preclinical pharmacology and research services to life science organizations.
- Where are PharmaLegacy Laboratories and BTS Research based?
- BTS Research is based in San Diego, California, United States.
- Who are the decision-makers at PharmaLegacy Laboratories?
- Fundz holds 1 contact at PharmaLegacy Laboratories. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Health Care and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Organon successfully acquires Dermavant Sciences Ltd. to expand dermatology portfolio (October 28, 2024)
- Trinity Biotech plc acquires EpiCapture Limited to expand into oncology diagnostics (October 25, 2024)
- LabGenomics USA Completes Acquisition of IMD CLIA Labs to Expand Diagnostic Services (October 25, 2024)
- Merck completes acquisition of Modifi Biosciences, Inc. to advance DNA modification enabled cancer therapeutics (October 23, 2024)
- Access Genetics dba OralDNA® Labs acquires Breakthrough Point-of-Care Rapid PCR Technology from Sensible Diagnostics Inc. (October 22, 2024)
- AscellaHealth completes strategic acquisition of CHAPPER healthcare to expand global specialty pharmaceutical wholesale and product distribution services (October 17, 2024)
Who to call at PharmaLegacy Laboratories, and when
When PharmaLegacy Laboratories changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day PharmaLegacy Laboratories raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PharmaLegacy Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PharmaLegacy Laboratories. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PharmaLegacy Laboratories makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BTS Research?
BTS Research was acquired by PharmaLegacy Laboratories. The deal was reported on September 16, 2024. PharmaLegacy Laboratories is a reputable provider of in vitro and in vivo preclinical drug development services, offering a wide range of preclinical pharmacology and research services to life science organizations. PharmaLegacy Laboratories is privately held and operates in Health Care.
When did PharmaLegacy Laboratories acquire BTS Research?
PharmaLegacy Laboratories's acquisition of BTS Research was reported on September 16, 2024. PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has strategically acquired BTS Research, a San Diego-based CRO. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BTS Research do?
It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.